| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5dc48fd971de53bc24587d30a53bb366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d7e42aa9ab212c249bf1b9169517012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f608437b78674d77bd371f635a364d56 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-022 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-565 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate |
1998-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71123da57b5e588fedb168e26b5bc495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7a4822e18e066a55186756d90ecbf41 |
| publicationDate |
1999-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9910516-A2 |
| titleOfInvention |
Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| abstract |
Methods and pharmaceutical compositions for modifying cells of a mammalian recipient with DNA encoding a secreted protein such as human interferon in situ are provided. The methods include forming a secreted protein expression system in vivo or ex vivo and administering the expression system to the mammalian recipient. The expression system and methods are useful for the localized and systemic delivery of interferons in situ. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007104633-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100422322-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1389043-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2002303503-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017214706-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1389043-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02056918-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02095041-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7534424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02056918-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1835032-A1 |
| priorityDate |
1997-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |